Showing results (361-370 of 638) with videos related to

Sort By:
Pageof 64
Journal of Cardiovascular Pharmacology|November 15, 2000
Regulation of the myocardial endothelin system by angiotensin-II and losartanP E McEwan, L Sherry, C J Kenyon, et al.
Circulation|December 16, 1998
Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivoP E McEwan, G A Gray, L Sherry, et al.
Journal of Cardiovascular Pharmacology|April 13, 2004
Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteriesM R Miller, K Okubo, M J Roseberry, et al.
British Heart Journal|November 1, 1994
Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcomeI Wieczorek, W G Haynes, D J Webb, et al.
Optics Express|February 7, 2018
Novel thermal annealing methodology for permanent tuning polymer optical fiber Bragg gratings to longer wavelengthsA Pospori, C A F Marques, G Sagias, et al.
Endocrinology|December 1, 1995
Alpha 2-macroglobulin conformation determines binding affinity for activin A and plasma clearance of activin A/alpha 2-macroglobulin complexC A Niemuller, K J Randall, D J Webb, et al.
BMJ (Clinical Research Ed.)|April 29, 1998
Contribution of parental blood pressures to association between low birth weight and adult high blood pressure: cross sectional studyB R Walker, A McConnachie, J P Noon, et al.
Circulation|April 1, 1996
Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular diseaseJ R Petrie, S Ueda, D J Webb, et al.
The Biochemical Journal|December 1, 1995
Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of ratD J Webb, K P Crookston, N L Figler, et al.
Heart (British Cardiac Society)|September 22, 1999
Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgeryB Prendergast, D E Newby, L E Wilson, et al.
Pageof 64